搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
labiotech
12 小时
Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for ...
Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...
labiotech
2 天
The rise of cancer vaccines: A new era in immunotherapy
Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...
labiotech
1 天
Process intensification: Fueling biopharma success at warp speed
Learn about process intensification in biopharma, key strategies for success, and solutions to overcome manufacturing ...
labiotech
5 天
Trump’s healthcare picks: Who they are and what they mean for the biopharma industry
Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.
labiotech
6 天
2025 Biotech conferences and events
Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for ...
labiotech
7 天
Charcot–Marie–Tooth disease: what’s going on in the clinical field?
Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.
labiotech
8 天
Seven miRNA-focused companies pioneering new therapies in 2024
Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...
labiotech
8 天
Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success
Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...
labiotech
9 天
Evotec on the brink of acquisition: At what cost for the biotech industry?
As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...
labiotech
12 天
Can AlphaFold3’s open-source platform revolutionize the way we discover drugs?
Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.
labiotech
16 天
What is Abcam’s founder, Jonathan Milner, up to?
Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...
labiotech
10 个月
Eight areas where gene therapy shines
Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈